Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/7156
Title: Financial Performance of Foreign Direct Invested Pharmaceutical Units in India
Authors: Srinivasan, K.
Deo, M.
Srinivasan, P.
Keywords: FDI, Pharmaceutical Units, Leverage Effect, Performance Ratios, Du Pont Analysis
Issue Date: 2010
Publisher: University of Kelaniya
Citation: Srinivasan, K., Deo, Malabika and Srinivasan, P., 2010. Financial Performance of Foreign Direct Invested Pharmaceutical Units in India, In: Proceedings of the 1st International Conference on Business and Information, University of Kelaniya.
Abstract: This paper examines the performance of select Foreign Direct Invested (FDI) assisted pharmaceutical units in India for the period from 1st April 1999 to 31st March 2008. The dataset has been retrieved from CMIE Prowess database and Organization of Pharmaceuticals Producers of India (OPPI) for 23 FDI assisted pharmaceutical units and evaluated through the following ratios Capital Structure Ratios, Liquidity Ratios, Profitability Ratios, Du Pont Analysis and Return on Investment. Our findings suggest, that the capital has been efficiently used in gearing profits, but there was a slight decline in return on equity due to over utilization of outsider‟s capital it was the major reason for showing negative effects. But, all the sample units show a galloping trend during the study period. The liquidity position and short-term solvency positions have improved, because of this the sales have increased, the leverage effects was not found favorable for certain units. Finally, our study suggests that the mark of FDI assisted pharmaceutical units for different ratios report a positive direction throughout the study and provoked the strength of Indian economy for the future.
URI: 
http://repository.kln.ac.lk/handle/123456789/7156
Appears in Collections:ICBI 2010

Files in This Item:
File Description SizeFormat 
K Srinivasan.pdf228.27 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.